spectrila
medac gesellschaft fuer klinische spezialpraeparate mbh - asparagináza - prekurzorová bunková lymfoblastická leukémia-lymfóm - antineoplastické činidlá - spectrila je indikovaná ako súčasť protinádorovej kombinovanej liečby na liečbu akútna lymfoblastická leukémia (all) u pediatrických pacientov od narodenia do 18 rokov a dospelých.
fluorouracil accord 50 mg/ml injekčný a infúzny roztok
accord healthcare polska sp. z o.o., poľsko - fluóruracil - 44 - cytostatica
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
aminovenoes n-paed 10 %
fresenius kabi ab, Švédsko - aminokyseliny - 76 - infundibilia
biston
zentiva a.s., slovensko - karbamazepín - 21 - antiepileptica, anticonvulsiva
neurotop 200 mg
g.l. pharma gmbh, rakúsko - karbamazepín - 21 - antiepileptica, anticonvulsiva
neurotop retard 300 mg
g.l. pharma gmbh, rakúsko - karbamazepín - 21 - antiepileptica, anticonvulsiva
neurotop retard 600 mg
g.l. pharma gmbh, rakúsko - karbamazepín - 21 - antiepileptica, anticonvulsiva
nephrotect
fresenius kabi deutschland gmbh, nemecko - kombinácie - 76 - infundibilia
aminoplasmal 15 %
b.braun melsungen ag, nemecko - aminokyseliny - 76 - infundibilia